Ritonavir

Paul A. Pham, Pharm.D., John G. Bartlett, M.D., Alice Jenh Hsu, Pharm.D.

Ritonavir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Monkeypox

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

INDICATIONS

FDA

Treatment of HIV infection in combination with other antiretrovirals.
Pharmacokinetic enhancement of APV, ATV, DRV, FPV, SQV, TPV, and LPV.
Combined with nirmatrelvir for treatment of mild-moderate COVID-19 in those at high risk for severe illness.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INDICATIONS

FDA

Treatment of HIV infection in combination with other antiretrovirals.
Pharmacokinetic enhancement of APV, ATV, DRV, FPV, SQV, TPV, and LPV.
Combined with nirmatrelvir for treatment of mild-moderate COVID-19 in those at high risk for severe illness.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: November 3, 2022